- Home
- OCCIM vs NNNN Comparison
OCCIM vs NNNN Comparison
Compare OCCIM & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCCIM
- NNNN
- Stock Information
- Founded
- OCCIM N/A
- NNNN 2021
- Country
- OCCIM
- NNNN Germany
- Employees
- OCCIM N/A
- NNNN N/A
- Industry
- OCCIM
- NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- OCCIM
- NNNN Health Care
- Exchange
- OCCIM NYSE
- NNNN Nasdaq
- Market Cap
- OCCIM N/A
- NNNN N/A
- IPO Year
- OCCIM N/A
- NNNN 2025
- Fundamental
- Price
- OCCIM $24.26
- NNNN $6.70
- Analyst Decision
- OCCIM
- NNNN
- Analyst Count
- OCCIM 0
- NNNN 0
- Target Price
- OCCIM N/A
- NNNN N/A
- AVG Volume (30 Days)
- OCCIM N/A
- NNNN 45.0K
- Earning Date
- OCCIM N/A
- NNNN 01-01-0001
- Dividend Yield
- OCCIM N/A
- NNNN N/A
- EPS Growth
- OCCIM N/A
- NNNN 858.51
- EPS
- OCCIM N/A
- NNNN 0.10
- Revenue
- OCCIM N/A
- NNNN $9,502,048.00
- Revenue This Year
- OCCIM N/A
- NNNN N/A
- Revenue Next Year
- OCCIM N/A
- NNNN N/A
- P/E Ratio
- OCCIM N/A
- NNNN $66.91
- Revenue Growth
- OCCIM N/A
- NNNN 8.43
- 52 Week Low
- OCCIM N/A
- NNNN $5.18
- 52 Week High
- OCCIM N/A
- NNNN $7.82
- Technical
- Relative Strength Index (RSI)
- OCCIM N/A
- NNNN N/A
- Support Level
- OCCIM N/A
- NNNN N/A
- Resistance Level
- OCCIM N/A
- NNNN N/A
- Average True Range (ATR)
- OCCIM 0.00
- NNNN 0.00
- MACD
- OCCIM 0.00
- NNNN 0.00
- Stochastic Oscillator
- OCCIM 0.00
- NNNN 0.00
About OCCIM OFS CREDIT COMPANY INC 7.875% PREFERRD STCK SERIES F USD25.0
OFS Credit Co Inc is a non-diversified, closed-end management investment company. Its investment objective is to generate current income, with a secondary objective to generate capital appreciation primarily through investment in collateralized loan obligation (CLO) equity and debt securities. The company invests in floating rate credit instruments and other structured credit investments, including; collateralized loan obligation (CLO) debt and subordinated (i.e., residual or equity) securities; traditional corporate credit investments, including leveraged loans and high yield bonds; opportunistic credit investments, including stressed and distressed credit situations and long/short credit investments; and other credit-related instruments.